个人信息Personal Information
特任研究员
电子邮箱：
学位：博士
- 暂无内容
- 1) Jing Jin#, Peidong Yan#, Dongyao Wang#*, Lin Bai#, Hao Liang, Xiaoyu Zhu, Huaiping Zhu, Chen Ding*, Haiming Wei*, Yi Wang*. Targeting lactylation reinforces NK cell cytotoxicity within the tumor microenvironment. Nature Immunology, June 10, 2025. https://doi.org/10.1038/s41590-025-02178-8.
- 2) Yunjia Li#, Lin Bai#, Hao Liang#, Peidong Yan#, Hao Chen#, Zhuoxian Cao#, Yiqing Shen, Zhongyv Wang, Mei Huang, Bin He, Quan Hao, Yide Mei, Haiming Wei, Chen Ding*, Jing Jin*, Yi Wang*. A BPTF-specific PROTAC degrader enhances NK cell-based cancer immunotherapy. Molecular Therapy, 2025; 33(4):1566-1583..
- 3) Yunjia Li#, Yiqing Shen#, Hao Chen#, Lin Xue, Mei Huang, Haiming Wei, Jing Jin*, Yi Wang*. A heparanase-specific LYTAC degrader reinforces natural killer cell cytotoxicity within the tumor microenvironment. Cell Reports Physical Science, 2024, 5 (12)..
- 4) Jing Jin#,* Lin Bai#, Dongyao Wang#, Wei Ding, Zhuoxian Cao, Peidong Yan, Yunjia Li, Lulu Xi, Yuxing Wang, Xiaohu Zheng, Haiming Wei, Chen Ding*, Yi Wang*. SIRT3-dependent delactylation of cyclin E2 prevents hepatocellular carcinoma growth. EMBO Reports, 2023, 24 (5), e56052..
- 5) Xinyuan Xu#, Qian Zhang#, Xufeng Wang#, Jing Jin#, Chengwei Wu#, Li Feng#, Xiuyan Yang, Mingzhu Zhao, Yingyi Chen, Shaoyong Lu, Zhen Zheng, Xiaobing Lan, Yi Wang*, Yan Zheng*, Xuefeng Lu*, Qiufen Zhang* Jian Zhang*. Discovery of a potent and highly selective inhibitor of SIRT6 against pancreatic cancer metastasis in vivo, Acta Pharmaceutica Sinica B, 2024; 14(3): 1302-1316..
- 6) Jing Jin#, Bin He#, Xiaoyu Zhang, Hening Lin*, Yi Wang*. SIRT2 reverses 4-oxononanoyl lysine modification on histones. J. Am. Chem. Soc., 2016, 138 (38), pp 12304–12307..
- 暂无内容
- 暂无内容
- 暂无内容